Review





Similar Products

plasminogen activator inhibitor type 1 pai 1 kit  (R&D Systems)
94
R&D Systems plasminogen activator inhibitor type 1 pai 1 kit
Plasminogen Activator Inhibitor Type 1 Pai 1 Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Mouse+Serpin+E1%2FPAI-1+DuoSet+ELISA/pm41917468-33-23-33
Average 94 stars, based on 1 article reviews
plasminogen activator inhibitor type 1 pai 1 kit - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
human pai 1 sandwich elisa kit  (Elabscience Biotechnology)
94
Elabscience Biotechnology human pai 1 sandwich elisa kit
Human Pai 1 Sandwich Elisa Kit, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Human+PAI1+(Plasminogen+Activator+Inhibitor+1)+ELISA+Kit/pm41744606-77-11-17
Average 94 stars, based on 1 article reviews
human pai 1 sandwich elisa kit - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
edta plasma tissue plasminogen activator tpa molecular innovations ipctpakta  (Innovative Research Inc)
92
Innovative Research Inc edta plasma tissue plasminogen activator tpa molecular innovations ipctpakta
Edta Plasma Tissue Plasminogen Activator Tpa Molecular Innovations Ipctpakta, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Porcine+Active+PAI-1+ELISA+Kit%2CPorcine+PAI-1+Activity+ELISA+Kit/pm41693475-83-81-87
Average 92 stars, based on 1 article reviews
edta plasma tissue plasminogen activator tpa molecular innovations ipctpakta - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
edta plasma plasminogen activator inhibitor 1 pai 1 molecular innovations  (Innovative Research Inc)
92
Innovative Research Inc edta plasma plasminogen activator inhibitor 1 pai 1 molecular innovations
Edta Plasma Plasminogen Activator Inhibitor 1 Pai 1 Molecular Innovations, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Porcine+Active+PAI-1+ELISA+Kit%2CPorcine+PAI-1+Activity+ELISA+Kit/pm41693475-83-72-78
Average 92 stars, based on 1 article reviews
edta plasma plasminogen activator inhibitor 1 pai 1 molecular innovations - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier
plasminogen activator inhibitor 1  (Innovative Research Inc)
94
Innovative Research Inc plasminogen activator inhibitor 1
Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.
Plasminogen Activator Inhibitor 1, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Mouse+Active+PAI-1+ELISA+Kit%2CMouse+PAI-1+Activity+ELISA+Kit/pmc12829123-47-38-43
Average 94 stars, based on 1 article reviews
plasminogen activator inhibitor 1 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
dog plasminogen activator inhibitor 1 serpine1 elisa kit  (Cusabio)
93
Cusabio dog plasminogen activator inhibitor 1 serpine1 elisa kit
Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.
Dog Plasminogen Activator Inhibitor 1 Serpine1 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasminogen+activator+inhibitor+1/SERPINE1/10__17221_slash_16_slash_2025___vetmed-34-38-46
Average 93 stars, based on 1 article reviews
dog plasminogen activator inhibitor 1 serpine1 elisa kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
plasminogen activator inhibitor 1  (Proteostasis Therapeutics)
86
Proteostasis Therapeutics plasminogen activator inhibitor 1
Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.
Plasminogen Activator Inhibitor 1, supplied by Proteostasis Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasminogen+activator+inhibitor+1/1+activator+inhibitor+plasminogen/pmc12620568-612-11-0
Average 86 stars, based on 1 article reviews
plasminogen activator inhibitor 1 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier
active plasminogen activator inhibitor 1 pai 1  (Innovative Research Inc)
93
Innovative Research Inc active plasminogen activator inhibitor 1 pai 1
Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator <t>inhibitor</t> <t>1</t> (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.
Active Plasminogen Activator Inhibitor 1 Pai 1, supplied by Innovative Research Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/plasminogen+activator+inhibitor+1/Human+PAI-1+ELISA+Kit%2CStandard+for+the+Human+PAI-1+ELISA+Kit/10__1182_slash_blood___2025___5252-6-17-40
Average 93 stars, based on 1 article reviews
active plasminogen activator inhibitor 1 pai 1 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator inhibitor 1 (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.

Journal: Research and Practice in Thrombosis and Haemostasis

Article Title: Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemia

doi: 10.1016/j.rpth.2025.103319

Figure Lengend Snippet: Hemostatic biomarkers in mouse models of acute myeloid leukemia (AML) and acute promyelocytic leukemia (APL). Levels of hemostatic biomarkers in control mice and mice bearing NB4-Luc cells (APL) or HL-60-Luc2 cells (AML) for (A) cell-free DNA (cfDNA), (B) thrombin-antithrombin complexes (TAT), (C) fibrinogen, (D) plasmin-antiplasmin complexes (PAP), (E) D-dimer, and (F) plasminogen activator inhibitor 1 (PAI-1). Control ( n = 7-9), APL mice ( n = 6 at 28 [ n = 2] or 31 [ n = 4] days for cfDNA, TAT and D-dimer, n = 7 at 29 [ n = 1] or 31 [ n = 6] days for fibrinogen, PAP, and PAI-1), and AML mice ( n = 9 at 45 [ n = 2], 48 [ n = 2], or 50 [ n = 5] days for cfDNA, TAT, and D-dimer. n = 6 at 51 days for fibrinogen, PAP, and PAI-1) are shown. (B, C, E, and F) An ordinary one-way anova followed by Tukey’s test was used for TAT, fibrinogen, D-dimer, and PAI-1; (A and D) the Kruskal–Wallis test followed by Dunn’s test was used for cfDNA and PAP. ∗ P < .05; ∗∗ P < .01; ∗∗∗∗ P < .0001.

Article Snippet: Levels of different biomarkers in plasma were measured using commercial enzyme-linked immunosorbent assays: TAT (Siemens, cat number OWMG15), fibrinogen (Immunology Consultation Laboratory Inc, cat number E-90FIB), PAP (MyBioSource, cat number MBS2512896), D-dimer (Diagnostica Stago, cat number 00947), and plasminogen activator inhibitor 1 (PAI-1; Molecular Innovations, cat number IMSPAI1KTA). cfDNA was measured using the Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fisher Scientific, cat number P11496).

Techniques: Control